 PALO ALTO, Calif., April 21, 2021 PRNewswire -- Kodiak Sciences Inc. Nasdaq: KOD, a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today announced that management will present at the following upcoming virtual investor conferences: Truist Securities 2021 Life Sciences Summit on Tuesday, May 4 at 8:20 a.m. 